1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. PRIME MEDICINE INC
Prime Medicine Inc
XNAS: PRME
3.15 0.10 (3.28%)
2.2M
XNAS Volume

XNAS 21 Jul, 2026 1:09 PM (EDT)

Watchlist

Portfolio

Alert

Prime Medicine Inc - PRME - stock price prediction, stock price target, analyst ratings from 13 analysts

Prime Medicine Inc has a share price target of US$ 7, revenue growth forecast of 95.0%, and profit growth estimate of 5.1% for FY26, based on top 13 analyst calls.